1 |
Does regional vulnerability to normal ageing determine region-specific susceptibility in neurodegenerative disease? |
1 |
2 |
Do mechanisms of ageing at the nervous system tissue, cellular and molecular level determine regional vulnerability to both normal ageing and neurodegenerative disease? |
2 |
3 |
Can differential ageing conceptually extend across scales, from the individual to subcellular level? |
3 |
4 |
Are the initial sites affected by neurodegenerative pathology also those that are most prone to ageing? |
– |
5 |
Can the concept of regional susceptibility to ageing be extended across other age-related diseases, such as cardiovascular disease? |
– |
6 |
Is it experimentally tractable to directly compare the ageing status of single cells, cellular subregions, or individual organelles within cells? |
– |
7 |
How can an understanding of region-specific vulnerability to ageing and disease be used to guide therapeutic advance e.g. ASO delivery, cellular implantation? |
– |